PMDA drug package insert
ヒアレインS
PMDA OTC drug · 参天製薬（株） · package insert Sep 17, 2024
Key facts
| Brand names | ヒアレインS |
|---|---|
| Companies | 製造販売元／参天製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 一般点眼薬 |
| Package insert date | Sep 17, 2024 |
| PMDA document key | 300237_J2001000136 |
| PMDA company code | 300237 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: